US EditionPublished • loading... • Updated
BioLife Solutions, Inc. (BLFS) Stock Analysis: A Compelling 20.96% Potential Upside In The Thriving Cell And Gene Therapy Sector
Summary by DirectorsTalk Interviews
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.1 Articles
1 Articles
BioLife Solutions, Inc. (BLFS) Stock Analysis: A Compelling 20.96% Potential Upside In The Thriving Cell And Gene Therapy Sector
BioLife Solutions, Inc. (NASDAQ: BLFS) is making waves in the healthcare sector, particularly within the medical instruments and supplies industry. With a market capitalization of $1.27 billion, BioLife Solutions is carving out a significant niche in the cell and gene therapy (CGT) market, providing critical bioproduction products and services across the globe. Headquartered in Bothell, Washington, and operational since 1987, the company is posi…
Coverage Details
Total News Sources1
Leaning Left0Leaning Right0Center0Last UpdatedBias DistributionNo sources with tracked biases.
Bias Distribution
- There is no tracked Bias information for the sources covering this story.
Factuality
To view factuality data please Upgrade to Premium
